ID

30561

Descripción

A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" Trial; ODM derived from: https://clinicaltrials.gov/show/NCT00737529

Link

https://clinicaltrials.gov/show/NCT00737529

Palabras clave

Versiones (1)
  1. 14/6/18 14/6/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

14 de junio de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Mantle Cell Lymphoma NCT00737529

Inglés

Eligibility Mantle Cell Lymphoma NCT00737529

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
biopsy proven mantle cell lymphoma
Descripción

Mantle cell lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0334634
patients must have documents relapsed, refractory or pd after treatment with bortezomib
Descripción

Bortezomib | Recurrent disease | Refractory Disease | Progressive Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1176309
UMLS CUI [2]
C0277556
UMLS CUI [3]
C1514815
UMLS CUI [4]
C1335499
must have measureable disease on cross sectional imaging by ct
Descripción

Measurable Disease Cross-sectional imaging CT

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C3824793
UMLS CUI [1,3]
C0040405
eastern cooperative oncology group (ecog) performance score 0,1 or 2
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
willing to follow pregnancy precautions
Descripción

Contraceptive methods Willing

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0600109
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
any of the following laboratory abnormalities
Descripción

Laboratory test result abnormal

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0438215
absolute neutrophil count (anc) < 1,500 cells/mm3 (1.5 x 109/l)
Descripción

Absolute neutrophil count

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0948762
platelet count < 60,000/mm3 (60 x 109/l)
Descripción

Platelet Count measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032181
serum aspartate transaminase/serum glutamic oxaloacetic transaminase(ast/sgot) or alanine transaminase/serum glutamic pyruvic transaminase (alt/sgpt) > 3.0 x upper limit of normal (uln), except in patients with documented liver involvement by lymphoma.
Descripción

Aspartate aminotransferase increased | Alanine aminotransferase increased | Exception Liver Involvement with Lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0023884
UMLS CUI [3,3]
C1314939
UMLS CUI [3,4]
C0024299
serum total bilirubin > 1.5 x uln, except in cases of gilbert's syndrome and documented liver involvement by lymphoma.
Descripción

Elevated total bilirubin | Exception Gilbert Disease | Exception Liver Involvement with Lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0741494
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0017551
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0023884
UMLS CUI [3,3]
C1314939
UMLS CUI [3,4]
C0024299
calculated creatinine clearance (cockcroft-gault formula) of < 30 ml /min
Descripción

Estimation of creatinine clearance by Cockcroft-Gault formula

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2711451
patients who are candidates for high dose chemotherapy/allogeneic stem cell transplant are not eligible
Descripción

Patient need for High-dose chemotherapy | Patient need for Allogeneic Stem Cell Transplantation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0686904
UMLS CUI [1,2]
C1328050
UMLS CUI [2,1]
C0686904
UMLS CUI [2,2]
C2242529
history of active central nervous system (cns) lymphoma within the previous 3 months
Descripción

Central nervous system lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0742472
subjects not willing or unable to take deep vein thrombosis (dvt) prophylaxis
Descripción

DVT prophylaxis Unwilling | DVT prophylaxis Unable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0853245
UMLS CUI [1,2]
C0558080
UMLS CUI [2,1]
C0853245
UMLS CUI [2,2]
C1299582
prior history of malignancies, other than mcl, unless the patient has been free of the disease for ≥ 3 years
Descripción

Malignant Neoplasms | Exception Mantle cell lymphoma | Exception Disease Free of

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0334634
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0012634
UMLS CUI [3,3]
C0332296
positive human immunodeficiency virus (hiv) or active hepatitis b or c
Descripción

HIV Seropositivity | Hepatitis B | Hepatitis C

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C0019163
UMLS CUI [3]
C0019196
Volver a la parte superior de la página

Similar models

Eligibility Mantle Cell Lymphoma NCT00737529

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Mantle cell lymphoma
Item
biopsy proven mantle cell lymphoma
boolean
C0334634 (UMLS CUI [1])
Bortezomib | Recurrent disease | Refractory Disease | Progressive Disease
Item
patients must have documents relapsed, refractory or pd after treatment with bortezomib
boolean
C1176309 (UMLS CUI [1])
C0277556 (UMLS CUI [2])
C1514815 (UMLS CUI [3])
C1335499 (UMLS CUI [4])
Measurable Disease Cross-sectional imaging CT
Item
must have measureable disease on cross sectional imaging by ct
boolean
C1513041 (UMLS CUI [1,1])
C3824793 (UMLS CUI [1,2])
C0040405 (UMLS CUI [1,3])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance score 0,1 or 2
boolean
C1520224 (UMLS CUI [1])
Contraceptive methods Willing
Item
willing to follow pregnancy precautions
boolean
C0700589 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Laboratory test result abnormal
Item
any of the following laboratory abnormalities
boolean
C0438215 (UMLS CUI [1])
Absolute neutrophil count
Item
absolute neutrophil count (anc) < 1,500 cells/mm3 (1.5 x 109/l)
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count < 60,000/mm3 (60 x 109/l)
boolean
C0032181 (UMLS CUI [1])
Aspartate aminotransferase increased | Alanine aminotransferase increased | Exception Liver Involvement with Lymphoma
Item
serum aspartate transaminase/serum glutamic oxaloacetic transaminase(ast/sgot) or alanine transaminase/serum glutamic pyruvic transaminase (alt/sgpt) > 3.0 x upper limit of normal (uln), except in patients with documented liver involvement by lymphoma.
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0023884 (UMLS CUI [3,2])
C1314939 (UMLS CUI [3,3])
C0024299 (UMLS CUI [3,4])
Elevated total bilirubin | Exception Gilbert Disease | Exception Liver Involvement with Lymphoma
Item
serum total bilirubin > 1.5 x uln, except in cases of gilbert's syndrome and documented liver involvement by lymphoma.
boolean
C0741494 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0017551 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0023884 (UMLS CUI [3,2])
C1314939 (UMLS CUI [3,3])
C0024299 (UMLS CUI [3,4])
Estimation of creatinine clearance by Cockcroft-Gault formula
Item
calculated creatinine clearance (cockcroft-gault formula) of < 30 ml /min
boolean
C2711451 (UMLS CUI [1])
Patient need for High-dose chemotherapy | Patient need for Allogeneic Stem Cell Transplantation
Item
patients who are candidates for high dose chemotherapy/allogeneic stem cell transplant are not eligible
boolean
C0686904 (UMLS CUI [1,1])
C1328050 (UMLS CUI [1,2])
C0686904 (UMLS CUI [2,1])
C2242529 (UMLS CUI [2,2])
Central nervous system lymphoma
Item
history of active central nervous system (cns) lymphoma within the previous 3 months
boolean
C0742472 (UMLS CUI [1])
DVT prophylaxis Unwilling | DVT prophylaxis Unable
Item
subjects not willing or unable to take deep vein thrombosis (dvt) prophylaxis
boolean
C0853245 (UMLS CUI [1,1])
C0558080 (UMLS CUI [1,2])
C0853245 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])
Malignant Neoplasms | Exception Mantle cell lymphoma | Exception Disease Free of
Item
prior history of malignancies, other than mcl, unless the patient has been free of the disease for ≥ 3 years
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0334634 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0012634 (UMLS CUI [3,2])
C0332296 (UMLS CUI [3,3])
HIV Seropositivity | Hepatitis B | Hepatitis C
Item
positive human immunodeficiency virus (hiv) or active hepatitis b or c
boolean
C0019699 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial